July 8, 2020 / 5:10 AM / a month ago

BRIEF-Cosmo Pharmaceuticals' Rifamycin SV MMX Gets Marketing Authorization In Italy

July 8 (Reuters) - COSMO PHARMACEUTICALS NV:

* ANNOUNCES GRANTING OF MARKETING AUTHORIZATION IN ITALY TO RIFAMYCIN SV MMX (STADMYCIN™) BY ITALIAN AIFA

* WILL RECEIVE A MILESTONE PAYMENT OF EUR 1.5M FROM E.G. DUE ON GRANT OF THIS MARKETING AUTHORIZATION Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below